Sign in
Active, not recruitingNo phase

Electroencephalographic Biomarker to Predict Postoperative Delirium

Key facts

Who runs it
University of Chile
Where
Chile2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
264 people, planned
Started
1 Sept 2023
Ended
30 Jun 2026
Type of study
Observational
Treatments tested
  • POD risk estimation using PEUMA
Record updated
20 November 2025

Who can take part

Age
60 years to 100 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age ≥ 60 years old
  • Scheduled for high-risk elective surgery
  • Need for at least 3 days of hospital stay after surgery
  • Surgery performed under general anesthesia
  • Written informed consent for participation in the trial

Who cannot take part

  • Patients using neuroleptics drug during the past 6 months
  • The use of ketamine or dexmedetomidine during surgery
  • Emergency surgery
  • Mechanical ventilation during the 72 after surgery
  • Patients with preoperative delirium or dementia
  • Patients with a history of encephalopathy, psychosis, stroke or brain trauma with neurologic sequels
  • Analphabetism
  • Patients who do not talk Spanish
  • Patients included in another clinical trial

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Acute post-operatory cognitive dysfunction states are one of the most important complications in older patients that underwent surgery. Among them postoperative delirium (POD) is the the most studied. Patients who develop delirium have poorer long-term outcomes, such as longer length of hospital stay, institutionalization at discharge, and even higher mortality, and consequently, the human and economic costs significantly increase for the health system. Here the research team will use an observational cohort, investigator blinded in five-center with a primary endpoint to validate intraoperative EEG analysis as a reliable biomarker of postoperative delirium.

The group in the trial

  • Patients at risk of developing POD

    * Patients older than 60 years * Scheduled for elective surgery of moderate or high risk (defined as that which requires a subsequent hospitalization of at least 3 days) under general anesthesia. * Signed informed consent.

    Treatment: POD risk estimation using PEUMA

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Electroencephalographic Biomarker to Predict the Development of Postoperative Delirium: a Protocol of an Observational Study in a Cohort of Patients From Five Centers
Record updated
20 November 2025